IL-10: An “Immunologic Scalpel” for Atherosclerosis?
- 1 December 1999
- journal article
- editorial
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 19 (12), 2823-2825
- https://doi.org/10.1161/01.atv.19.12.2823
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Extracellular Signal-Regulated Kinase, Stress-Activated Protein Kinase/c-Jun N-Terminal Kinase, and p38mapkAre Involved in IL-10-Mediated Selective Repression of TNF-α-Induced Activation and Maturation of Human Peripheral Blood Monocyte-Derived Dendritic CellsThe Journal of Immunology, 1999
- MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein BJournal of Clinical Investigation, 1999
- IL-10 up-regulates nitric oxide (NO) synthesis by lipopolysaccharide (LPS)-activated macrophages: improved control ofTrypanosoma cruziinfectionClinical and Experimental Immunology, 1998
- Reduction of atherosclerosis in mice by inhibition of CD40 signallingNature, 1998
- IL‐10 inhibits LPS‐induced human monocyte tissue factor expression in whole bloodBritish Journal of Haematology, 1998
- IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathwaysThe EMBO Journal, 1998
- A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice.Journal of Clinical Investigation, 1998
- IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophagesEuropean Journal of Immunology, 1998
- IL-4, IL-10 and IL-13 down-regulate monocyte-chemoattracting protein-1 (MCP-1) production in activated intestinal epithelial cellsClinical and Experimental Immunology, 1998
- Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis.Journal of Clinical Investigation, 1996